drugset / Trial / NCT06190483

Investigating the Role of Diazepam on Brain Function and Chemistry in Psychosis Risk

NCT06190483

RandomizedCrossoverQuadruple-blindHealth-services research

Summary

This study will investigate whether a single dose of diazepam (5mg) compared to placebo can modulate brain chemistry (GABA/glutamate levels) and function (blood flow, neural response and connectivity during tasks and at-rest) in 24 individuals at clinical high-risk for psychosis.

Timeline

Start
2019-07-24
Primary completion
2023-03-24
Completion
2023-03-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule 5 mg Oral

Indications